Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to approximately 50 countries internationally.

Based in the UK, the brand was launched in 2005 by Charles Rolls and Tim Warrillow to provide high quality, natural mixers which could accompany the growing demand for premium spirits. The Group now sells a range of 12 differentiated flavours to hotels, restaurants, bars and cafes ("On Trade") as well as supermarkets and off-licenses for retail purchase ("Off Trade"). Approximately 70 per cent. of the Group's sales were derived from outside of the UK in FY13 with the key overseas markets being the US, Spain, and Belgium.

The Group's mixers are designed to be accompaniments for alcoholic spirits or used in cocktails, although they can also be consumed on their own. Since 2005, the Company has launched at least one new product a year, which includes 4 variants of tonic water, 2 variants of ginger beer, 3 variants of lemonade, and one variant each of ginger ale, soda water and cola.

7 November 2014
Admission to AIM and first day of dealings


http://www.fever-tree.com/

Hic! :o)

Preliminary Results
RNS
RNS Number : 0075A
Fevertree Drinks PLC
21 March 2017
 
21st March 2017
 
Fevertree Drinks plc ("Fever-Tree")
 
Preliminary Results
 
Fever-Tree, the world's leading supplier of premium carbonated mixers, today announces its Preliminary Results for the year ended for 31 December 2016.
 
Financial highlights1:
 
·      Revenue up 73% to £102.2m (2015: £59.3m)
·      Gross profit margin of 55.2% (2015: 52.1%)
·      Adjusted EBITDA up 97% to £35.8m (2015: £18.2m)
·      Robust balance sheet with net cash at year end of £26.9m (2015: £11.6m)
·      Diluted EPS of 23.70 pence (2015: 11.48 pence)
·      Final dividend of 4.71 pence per share recommended to shareholders, bringing total dividend to 6.25 pence per share (2015: 3.08 pence per share)
 
Operational highlights:
 
·      Strong sales growth across all regions, channels and flavours, with a particularly notable performance in the UK
·      Continued penetration in the on-trade and off-trade including new listings with Asda in the UK, Target in the USA and Rewe in Germany
·      Expanded distribution of tonic water with British Airways across entire fleet and achieved listing of Naturally Light Tonic Water cans with EasyJet
·      Launch of new bespoke embossed bottles, successfully rolled out internationally in the period
·      Named the no.1 best-selling and no.1 trending tonic water in Drinks International's survey of world's top 250 bars for the third year running
 
Charles Rolls has today announced his intention to transition from Executive Deputy Chairman to become Non-Executive Deputy Chairman to the Company at the AGM in May 2017.
 
Tim Warrillow, CEO of Fever-Tree said:
 
"2016 has been another exceptional year of growth for Fever-Tree, with strong results achieved across all regions, channels and flavours, emphasising the global appeal of the Fever-Tree brand. As the pioneer and market leader of the premium mixer category, in both market share and reputation, our quality, award winning range of products continues to help drive the momentum towards premiumisation and simple long drink mixability that is transforming both the spirits and mixer categories worldwide.
As co-founder of Fever-Tree, Charles' support and advice will continue to be invaluable to the Company. We have an excellent and growing team in place and I personally look forward to continuing to work with Charles as we further build on the success of the brand that we created together 14 years ago.
We have had an encouraging start to 2017 and remain confident that we are increasingly well positioned to deliver further growth across the business."

 
____________________
1 The Preliminary Results refer to adjusted EBITDA. Adjusted EBITDA for the year ended December 31 2016 is operating profit of £34.4m before depreciation of £0.2m, amortisation of £0.7m and share based payment charges of £0.5m.
 

delighted to see a good chunk of selling on the news .... gave me the chance to top up

"We have had an encouraging start to 2017 and remain confident that we are increasingly well positioned to deliver further growth across the business."

BUT will there be further growth in profits this year?

I still hate this share :-)

21 Mar Shore Capital Buy 1,391.00 - - Reiterates

21 Mar Whitman Howard Hold 1,391.00 1,250.00 1,250.00 Reiterates

Join the club Skinny, have any directors sold and cashed in lately does anyone know?

well my purchase (top-up) this morning is already in the money, so hate this stock as much as you like guys ...... more like green eyes i reckon :-)

I've just taken 45 points from a cheeky S/B - still hate this share :-)

There's no stamp duty with these...why didn't someone tell me )-:

Why didn't you check

I just did, hence the above post.

what's the odds? ...... surely even if applicable, it's relative peanuts
on a sipp, i don't think stamp duty is ever payable on uk stocks

What are you on about Alf of course SD is due on the majority of shares on the LSE.

Also I don't Reguard 0.5% trivial when a short term trade is concerned.

Bit early to be on the source don't you think -);

no stamp duty on a sipp that's for sure .... i know as i've just seen the contract notes for this morning's buys

FEVR is an AIM stock - so no stamp duty since 2014.

Main market shares - SIPP or not, are subject to stamp duty.

yup, you're right skinny .... just looked back at a WTB contract note

Forbes
Investing #​MarketMoves

MAR 21, 2017 @ 01:10 PM 191 VIEWS The Little Black Book of Billionaire Secrets
Profits Have Doubled At This British Drinks Stock. Time To Buy In?

Beverages play Fever-Tree Drinks saw its share price advance again on Tuesday following a bubbly reception to full-year trading numbers.

The stock rose 2% from last night’s close and is again just a shade off recent record highs above £15.20 per share.

Fever-Tree Drinks announced that revenues exploded 72% during the 12 months to December 2016, to £102.2m. And this caused pre-tax profits to more than double from the prior period, to £34.3m.

Accompanying the results, chief executive Tim Warrillow commented that ‘2016 has been another exceptional year of growth for Fever-Tree, with strong results achieved across all regions, channels and flavours, emphasising the global appeal of the Fever-Tree brand.’

Global Superstar

The premium mixer manufacturer had a healthy UK market to thank in large part for last year’s astonishing performance. Fever-Tree sources 44% of total revenues from home.

A 124% sales surge during July-December saw full-year sales growth clock in at an astonishing 118%. This was up from the 84% rise punched during 2016.

And Fever-Tree enjoyed double-digit demand growth overseas, too. Sales to Continental Europe, the US and the so-called ‘rest of the world’ grew 39%, 55% and 88% respectively during 2016.

Surging spirits demand continues to drive profits to the stars at London's Fever-Tree D

Dark Arts

Fever-Tree is benefitting from growing demand across its Western markets for gin and tonic. But the business is also seeing huge opportunity from the rising popularity of dark spirits like rum and whisky. Accordingly the business is lining up a stream of new product launches for this category for 2017.

Fever-Tree commented that ‘we believe that an exciting opportunity exists to work alongside the premium spirits brands to reinvigorate the dark spirits category, in much the same way we approached the gin category over ten years ago.’

And Fever-Tree’s rising presence in the dark spirits segment certainly offers plenty of upside. While gin accounts for 6% of the global premium spirits category, darker spirits account for 60% of the total, the company notes.

Price Pounds Higher

A steady stream of positive updates has sent Fever-Tree’s stock value surging in recent times, the beverages brute advancing more than 120% during the past 12 months alone.

As a result Fever-Tree is looking at tad expensive, at least from a conventional standpoint. The company deals on a prospective P/E ratio of 57.5 times at present.

Still, I reckon this should not diminish Fever-Tree’s appeal as a savvy investment given the firm’s white-hot growth prospects. Indeed, the London manufacturer is anticipated to deliver further earnings expansion of 9% this year and 10% in 2018 alone.

And Fever-Tree’s exceptional growth outlook also bodes well for future dividends. Last year’s profits leap encouraged the firm to hike the final dividend to 4.71p per share, taking total rewards for 2016 to 6.25p. 2015’s reward stood at a far-more-modest 3.08p.

I reckon Fever-Tree’s improving position in what are rapidly-growing markets makes it one of the hottest growth bets out there.

Proactive investor -


Rollercoaster ride for Fevertree, but brokers still bullish
19:00 22 Mar 2017
“Fevertree is delivering growth that is significantly stronger and at higher margins than the peer group”

The 150ml cans introduced last year proved very popular, Fevertree said yesterday
It’s been an interesting couple of days for Fevertree Drinks PLC (LON:FEVR) investors this week.
The full-year results came out on Tuesday and, given that the numbers were pretty well-flagged in January’s trading update, they were fairly unsurprising.
The share price reaction on Wednesday morning was anything but, with shares almost immediately losing 7% as investors began to take profits.
After getting a beating for an hour or so on Tuesday, the price started to climb, a rise which continued for most of the day. By 3pm, shares were testing all-time highs and although they dipped slightly after that, they still closed 3% higher at £14.99.
Today (Wednesday) has followed a similar theme to that of yesterday although neither the fall nor the rise has been as dramatic.
Given the unusually erratic share price, it can be difficult to work out what to do if you’re a Fevertree investor. Shore Capital's Phil Carroll reckons he’s got the answer though: buy more.
“In terms of the outlook, management point to an encouraging start to the year which may be a slight disappointment to some investors,” the analyst said in a note to clients.
“But given the sheer momentum in the fourth quarter we see it more as management’s normal relatively prudent approach to managing expectations.”
Carroll acknowledges it won’t be an easy task to beat last year’s growth in 2017, but is still confident in the tonic maker’s ability to deliver more upgrades.
“We still believe Fevertree is capable of delivering further upgrades as we progress through the year given its excellent brand and product proposition and a lack of effective competition.”
So which areas could prove particularly lucrative for the London-based firm in 2017?
Carroll thinks Fevertree is being sensible in investing in its dark spirits mixers, such as ginger beer, which could rake in big bucks, particularly in the US.
“We note [the company] has a strong new product development pipeline which includes a range of mixers targeting the dark spirits market which in premium spirits is 10x the size of the gin market,” Carroll said.
And what if shares take another kicking? Carroll sticks with his advice to snap shares up in the event of another drop in the share price.
“Should there be a ‘weaker’ period of growth that disappoints the market, we would see this as an opportunity to acquire the stock.”
Shares were down 5% at £14.22 on Wednesday afternoon.

24 Mar
RBC Capital...
1,700.00
Outperform

PE 129

I read somewhere !!!